Oroxyloside protects against dextran sulfate sodium-induced colitis by inhibiting ER stress via PPARγ activation

Abstract

Ulcerative colitis (UC), a prevalent form of inflammatory bowel disease (IBD), may result from immune system dysfunction, leading to the sustained overproduction of reactive oxygen species (ROS) and subsequent cellular oxidative stress damage. Recent studies have identified both peroxisome proliferator-activated receptor-γ (PPARγ) and endoplasmic reticulum (ER) stress as critical targets for the treatment of IBD. Oroxyloside (C₂₂H₂₀O₁₁), derived from the root of Scutellaria baicalensis Georgi, has traditionally been used in treating inflammatory diseases. In this study, we investigated the molecular mechanisms by which oroxyloside mitigates dextran sulfate sodium (DSS)-induced colitis. We examined the effects of oroxyloside on ROS-mediated ER stress in colitis, including the protein expressions of GRP78, p-PERK, p-eIF2α, ATF4, and CHOP, which are associated with ER stress. The beneficial impact of oroxyloside was reversed by the PPARγ antagonist GW9662 (1 mg·kg⁻¹, i.v.) in vivo. Furthermore, oroxyloside decreased pro-inflammatory cytokines and ROS production in both bone marrow-derived macrophages (BMDM) and the mouse macrophage cell line RAW 264.7. However, PPARγ siRNA transfection blocked the anti-inflammatory effect of oroxyloside and even abolished ROS generation and ER stress activation inhibited by oroxyloside in vitro. In conclusion, our study demonstrates that oroxyloside ameliorates DSS-induced colitis by inhibiting ER stress via PPARγ activation, suggesting that oroxyloside might be a promising effective agent for IBD.

Keywords

Oroxyloside / ER stress / PPARγ / Colitis

References

[1] Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?[J]. World J Gastroenterol, 2006, 12(38): 6102-6108.

[2] Edward V Loftus Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences[J]. Gastroenterology, 2004, 126(6): 1504-1517.

[3] Satsangi J, Silverberg MS, Vermeire ES, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications[J]. Gut, 2006, 55(6): 749-753.

[4] Bertolotti A, Wang X, Novoa I, et al. Increased sensitivity to dextran sodium sulfate colitis in IRE1beta-deficient mice[J]. J Clin Invest, 2001, 107(5): 585-593.

[5] Cao SS, Zimmermann EM, Chuang BM, et al. The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice[J]. Gastroenterology, 2013, 144(5): 989-1000.e6.

[6] Rutkowski T, Kaufman RJ. A trip to the ER: coping with stress[J]. Trends Cell Biol, 2004, 14(1): 20-28.

[7] Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation[J]. Science, 2011, 334(6059): 1081-1086.

[8] Rutkowski DT, Arnold SM, Miller CN, et al. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins[J]. PLoS Biol, 2006, 4(11): e374.

[9] Zinszner H, Kuroda M, Wang X, et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum[J]. Genes Dev, 1998, 12(7): 982-995.

[10] Oyadomari S, Koizumi A, Takeda K, et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes[J]. J Clin Invest, 2002, 109(4): 525-532.

[11] Feng B, Yao PM, Li Y, et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages[J]. Nat Cell Biol, 2003, 5(9): 781-792.

[12] Song B, Scheuner D, Ron D, et al. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes[J]. J Clin Invest, 2008, 118(10): 3378-3389.

[13] Lin JH, Li H, Yasumura D, et al. IRE1 signaling affects cell fate during the unfolded protein response[J]. Science, 2007, 318(5852): 944-949.

[14] Thorp E, Li G, Seimon TA, et al. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe^-/- and Ldlr^-/- mice lacking CHOP[J]. Cell Metab, 2009, 9(5): 474-481.

[15] Shkoda A, Ruiz PA, Daniel H, et al. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation[J]. Gastroenterology, 2007, 132(1): 190-207.

[16] Hu S, Ciancio MJ, Lahav M, et al. Translational inhibition of colonic epithelial heat shock proteins by IFN-gamma and TNF-alpha in intestinal inflammation[J]. Gastroenterology, 2007, 133(6): 1893-1904.

[17] Heazlewood CK, Cook MC, Eri R, et al. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis[J]. PLoS Med, 2008, 5(3): e54.

[18] Kaser A, Lee AH, Frankea A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease[J]. Cell, 2008, 134(5): 743-756.

[19] Desreumaux P, Dubuquoy L, Nutten S, et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies[J]. J Exp Med, 2001, 193(7): 827-38.

[20] NakajimaA A, Wada K, Miki H, et al. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury[J]. Gastroenterology, 2001, 120(2): 460-469.

[21] Su CG, Wen X, Bailey ST, et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response[J]. J Clin Invest, 1999, 104(4): 383-389.

[22] Gold PW, Licinio J, Pavlatou MG. Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-gamma systems[J]. Mol Psychiatry, 2013, 18(2): 154-165.

[23] Ikeda J, Ichiki T, Takahara Y, et al. PPARgamma agonists attenuate palmitate-induced ER stress through up-regulation of SCD-1 in macrophages[J]. PLoS One, 2015, 10(6): e0128546.

[24] Takahashi N, Yoshizaki T, Hiranaka N, et al. Endoplasmic reticulum stress suppresses lipin-1 expression in 3T3-L1 adipocytes[J]. Biochem Biophys Res Commun, 2013, 431(1): 25-30.

[25] Ren Y, Sun C, Sun Y, et al. PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation[J]. Vascul Pharmacol, 2009, 51(2-3): 169-174.

[26] Aoun P, Simpkins JW, Agarwal N. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells[J]. Invest Ophthalmol Vis Sci, 2003, 44(7): 2999-3004.

[27] Bordet R, Ouk T, Petrault O, et al. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases[J]. Biochem Soc Trans, 2006, 34(Pt 6): 1341-6.

[28] Yi JH, Park SW, Kapadia R, et al. Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage[J]. Neurochem Int, 2007, 50(7-8): 1014-1027.

[29] Tureyen K, Kapadia R, Owen KK, et al. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents[J]. J Neurochem, 2007, 101(1): 41-56.

[30] Sun Y, Lu N, Ling Y, et al. Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells[J]. Eur J Pharmacol, 2009, 603(1-3): 22-28.

[31] Li HN, Nie FF, Liu W, et al. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo[J]. Toxicology, 2009, 257(1-2): 80-85.

[32] Wang X, Sun Y, Zhao Y, et al. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation[J]. Biochem Pharmacol, 2016, 106: 70-81.

[33] Yao J, Pan D, Zhao Y, et al. Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway[J]. Immunology, 2014, 143(2): 241-257.

[34] Mu R, Qi Q, Gu H, et al. Involvement of p53 in oroxylin A-induced apoptosis in cancer cells[J]. Mol Carcinog, 2009, 48(12): 1159-1169.

[35] Zhao Y, Yao J, Wu XP, et al. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway[J]. Mol Carcinog, 2015, 54(Suppl 1): E81-E93.

[36] Zhao Y, Yao J, Wu X P, et al. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway[J]. Mol Carcinog, 2014, 54(S1): E81-E93.

[37] Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice[J]. Gastroenterology, 1990, 98(3): 694-702.

[38] Hickey MJ. MPO and neutrophils: a magnetic attraction[J]. Blood, 2011, 117(4): 1103-1104.

[39] Reumaux D, De Boer M, Meijer AB, et al. Expression of myeloperoxidase (MPO) by neutrophils is necessary for their activation by anti-neutrophil cytoplasm autoantibodies (ANCA) against MPO[J]. J Leukoc Biol, 2003, 73(6): 841-849.

[40] Egger B, Bajaj-Elliott M, Macdonald TT, et al. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency[J]. Digestion, 2000, 62(4): 240-248.

[41] Garside P. Cytokines in experimental colitis[J]. Clin Exp Immunol, 1999, 118(3): 337-339.

[42] Araki Y, Andoh A, Fujiyama Y. The free radical scavenger edaravone suppresses experimental dextran sulfate sodium-induced colitis in rats[J]. Int J Mol Med, 2003, 12(1): 125-129.

[43] Clarke HJ, Chambers JE, Liniker E, et al. Endoplasmic reticulum stress in malignancy[J]. Cancer Cell, 2014, 25(5): 563-573.

[44] Mohamadzadeh M, Pfeiler EA, Brown JB, et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid[J]. Proc Natl Acad Sci USA, 2011, 108(Suppl 1): 4623-4630.

[45] Danese S, Fiocchi C. Ulcerative colitis[J]. N Engl J Med, 2011, 365(18): 1713-1725.

[46] Baumgart DC, Sandborn WJ. Crohn’s disease[J]. Lancet, 2012, 380(9853): 1590-605.

[47] Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks[J]. J Biomed Biotechnol, 2012, 2012: 718617.

[48] Feige JN, Gelman L, Michalik L, et al. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions[J]. Prog Lipid Res, 2006, 45(2): 120-159.

[49] Lefebvre M, Paulweber B, Fajas L, et al. Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells[J]. J Endocrinol, 1999, 162(3): 331-340.

[50] Katayama K, Wada K, Nakajima A, et al. A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model[J]. Gastroenterology, 2003, 124(5): 1315-1324.

[51] StroberR W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation[J]. Annu Rev Immunol, 2002, 20: 495-549.

[52] Oz HS, Chen TS, Mcclain CJ, et al. Antioxidants as novel therapy in a murine model of colitis[J]. J Nutr Biochem, 2005, 16(5): 297-304.

[53] Todd DJ, Lee AH, Glimcher LH. The endoplasmic reticulum stress response in immunity and autoimmunity[J]. Nat Rev Immunol, 2008, 8(9): 663-74.

[54] Schroder M, Kaufman RJ. The mammalian unfolded protein response[J]. Annu Rev Biochem, 2005, 74: 739-789.

[55] Winnay JN, Boucher J, Mori MA, et al. A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response[J]. Nat Med, 2010, 16(4): 438-445.

[56] Takahashi A, Masuda A, Sun M, et al. Oxidative stress-induced apoptosis is associated with alterations in mitochondrial caspase activity and Bcl-2-dependent alterations in mitochondrial pH (pHm)[J]. Brain Res Bull, 2004, 62(6): 497-504.

[57] Heta C, Bernasconi P, Fisher J, et al. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha[J]. Science, 2006, 312(5773): 572-576.

[58] Martin-Perez R, Palacios C, Yerbes R, et al. Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathway[J]. Cancer Res, 2014, 74(6): 1766-1777.

[59] Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?[J]. Nat Rev Drug Discov, 2009, 8(7): 579-591.

[60] Zhou Y, Guo Y, Zhu Y, et al. Dual PPARγ/ɑ agonist oroxyloside suppresses cell cycle progression by glycolipid metabolism switch-mediated increase of reactive oxygen species levels[J]. Free Radical Biol Med, 2021, 167: 205-217.

[61] Tang Y, Wei K, Liu L, et al. Activation of PPARγ protects obese mice from acute lung injury by inhibiting endoplasmic reticulum stress and promoting mitochondrial biogenesis[J]. PPAR Re, 2022, 2022: 7888937.

Funding

Science and Technology Program of State Administration for Market Regulation(2021MK136)

Science and Technology Program of Jiangsu Market Supervision and Administration Bureau(KJ2022024)

Jiangsu Postgraduate Research and Practice Innovation Program(KYCX22_0794)